These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5151034)

  • 21. [Notes on 0.03% phospholine iodide, with more than 4 years' experience].
    Corbel MM; Leser C; François P
    Bull Soc Ophtalmol Fr; 1976 Mar; 76(3):249-50. PubMed ID: 1024748
    [No Abstract]   [Full Text] [Related]  

  • 22. Cystoid macular edema associated with topical echothiophate iodide.
    Halperin LS; Goldman HB
    Ann Ophthalmol; 1993 Dec; 25(12):457-8. PubMed ID: 8129329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The frequency of cataract after miotic therapy.
    Axelsson U; Holmberg A
    Acta Ophthalmol (Copenh); 1966; 44(3):421-9. PubMed ID: 5953238
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of various miotics on cataract formation.
    Abraham SV; Teller JJ
    Br J Ophthalmol; 1969 Dec; 53(12):833-8. PubMed ID: 5386373
    [No Abstract]   [Full Text] [Related]  

  • 25. [Phospholine iodide compared with pilocarpine in the management of simple glaucoma].
    Knapp E
    Klin Monbl Augenheilkd; 1968 Mar; 152(3):391-5. PubMed ID: 5670394
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of miotics on the lens.
    Firth JM; Vucicevic ZM; Tsou KC
    Ann Ophthalmol; 1973 Jun; 5(6):685-90. PubMed ID: 4718633
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental studies of the action of a cholinesterase inhibitor (phospholine iodide) on the permeability of the crystalline lens to cations].
    Secchi AG; Levi Minzi S; Segato T; Steindler P
    Ann Ottalmol Clin Ocul; 1971 Jan; 97(1):9-14. PubMed ID: 5122648
    [No Abstract]   [Full Text] [Related]  

  • 28. Experimental miotic cataract. II. Permeability, cation transport, and intermediary metabolism.
    Michon J; Kinoshita JH
    Arch Ophthalmol; 1968 May; 79(5):611-6. PubMed ID: 5689549
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of subcapsular cataracts in aniridic vervet monkeys by echothiophate.
    Kaufman PL; Axelsson U
    Invest Ophthalmol; 1975 Nov; 14(11):863-6. PubMed ID: 810455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Some results of the use of 0.125 per cent phospholine iodide in the medical treatment of glaucoma].
    Ardouin M; Urvoy M; Lefranc J; Garnier JP
    Bull Soc Ophtalmol Fr; 1966 Jan; 66(1):71-3. PubMed ID: 5940781
    [No Abstract]   [Full Text] [Related]  

  • 31. Dose-response analysis of echothiophate iodide.
    Harris LS
    Arch Ophthalmol; 1971 Nov; 86(5):503-5. PubMed ID: 5114443
    [No Abstract]   [Full Text] [Related]  

  • 32. Lens opacities and organophosphate cholinesterase-inhibiting agents.
    Pietsch RL; Bobo CB; Finklea JF; Vallotton WW
    Am J Ophthalmol; 1972 Feb; 73(2):236-42. PubMed ID: 5015904
    [No Abstract]   [Full Text] [Related]  

  • 33. Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs.
    Holland MG
    Ann Ophthalmol; 1974 May; 6(5):447-50 passim. PubMed ID: 4208894
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of phospholine-iodide on the energy metabolism of the lens.
    Tarkkanen A; Härkönen M
    Ophthalmologica; 1969; 158 Suppl():455-61. PubMed ID: 4243274
    [No Abstract]   [Full Text] [Related]  

  • 35. Echothiophate cataracts in monkeys. Electron microscopy and microradiography.
    Philipson B; Kaufman PL; Fagerholm P; Axelsson U; Bárány EH
    Arch Ophthalmol; 1979 Feb; 97(2):340-6. PubMed ID: 121693
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood cholinesterase activity of glaucoma patients treated with phospholine iodide.
    De Roetth A; Wong A; Dettbarn W; Rosenberg P; Wilensky JG
    Am J Ophthalmol; 1966 Nov; 62(5):834-8. PubMed ID: 5928831
    [No Abstract]   [Full Text] [Related]  

  • 37. Echothiophate iodide induced transient hyper- and hypothyroidism.
    Mezer E; Krivoy N; Scharf J; Miller B
    J Glaucoma; 1996 Jun; 5(3):191-2. PubMed ID: 8795758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lenticular opacities in glaucoma patients receiving echothiophate iodide therapy. Preliminary report.
    De Roetth A
    JAMA; 1966 Feb; 195(8):664-6. PubMed ID: 5951770
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cataractogenic action of corticosteroids in collagenoses].
    Belousova ZF
    Oftalmol Zh; 1978; 33(4):275-7. PubMed ID: 673301
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of 0.03% phospholine eyewash after eight years of use].
    Corbel M; Leser C
    Bull Soc Ophtalmol Fr; 1979; 79(8-9):741-3. PubMed ID: 555365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.